ARTHUR DAVID: Open Payments
NPI 1235135997 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 53 payments from 12 companies in 2025. Trend: 2023 $813 · 2024 $712 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $481 |
| Lilly USA, LLC | 10 | $174 |
| Exact Sciences Corporation | 5 | $109 |
| Novo Nordisk Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Braeburn Inc. | 2 | $42 |
| Orexo US, Inc. | 2 | $37 |
| Indivior Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
Products named: VRAYLAR, QULIPTA, MOUNJARO, Cologuard Collection Kit, CAPLYTA, BRIXADI, UBRELVY, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
